Moderate-low-efficacy disease-modifying therapiesIntervention1 paperLatestJournal of Neuroimmunology·May 19As time goes by: Treatment challenges in elderly people with multiple sclerosisSystematic review of studies in peopleMultiple sclerosisPaper
Journal of Neuroimmunology·May 19As time goes by: Treatment challenges in elderly people with multiple sclerosisSystematic review of studies in peopleMultiple sclerosisPaper